In a recent development, the Rosen Law Firm, a prominent global legal entity specializing in investor rights, has initiated an inquiry into possible fiduciary duty violations by the directors and officers of Edwards Lifesciences Corporation (NYSE: EW). This inquiry raises significant concerns for shareholders of the company, prompting the firm to invite current investors to provide information and participate in the investigation.
### Investigation Details
The Rosen Law Firm’s investigation focuses on potential breaches of fiduciary responsibilities, which are critical for maintaining trust between a company’s leadership and its shareholders. Investors who currently hold shares in Edwards Lifesciences are encouraged to visit the firm’s dedicated website for further details regarding the ongoing inquiry. Interested parties can also reach out to Phillip Kim, an attorney at the firm, through a toll-free number or via email for personalized assistance.
In their announcement, the law firm emphasized the importance of selecting experienced legal counsel with a proven track record in securities class actions. They pointed out that many firms issuing similar notices may lack the necessary experience and resources, which could affect the outcomes for investors. The Rosen Law Firm prides itself on a history of success, having achieved notable settlements in various securities class actions, including a record-breaking case against a Chinese company in the past.
### Firm’s Accomplishments
The Rosen Law Firm has established itself as a leader in the field of securities litigation, consistently ranking among the top firms for the number of settlements achieved. Since 2013, it has maintained a position within the top four firms according to ISS Securities Class Action Services. Notably, in the year 2019 alone, the firm secured over $438 million for investors, showcasing its commitment to protecting shareholder interests.
The firm’s founding partner, Laurence Rosen, has garnered recognition for his contributions to the plaintiffs’ bar, being named a “Titan of Plaintiffs’ Bar” by Law360. Furthermore, many attorneys from the firm have been acknowledged by prestigious publications such as Lawdragon and Super Lawyers, reaffirming the firm’s reputation in the legal community.
As the investigation unfolds, the Rosen Law Firm will continue to provide updates through various social media platforms, ensuring that interested investors stay informed about their rights and potential actions they can take. Shareholders are encouraged to remain vigilant and consider the implications of this investigation on their investments in Edwards Lifesciences Corporation. For more information about the investigation, visit the law firm’s official website or connect with them through their social media channels.
Related
